Expert consensus for clinical appliance of venlafaxine controlled release formulation
吴文源,黄继忠,司天梅,许秀峰,梅其一,季建林,李惠春,张宁,陆峥
DOI: https://doi.org/10.3969/j.issn.1000-6729.2013.07.013
2013-01-01
Abstract:Venlafaxine is one of substances of serotonin and noradrenaline reuptake inhibitors(SNRIs),which is regarded as the first-line drug for depressive disorder and generalized anxiety disorder by several practice guidelines across the world,as well as an effective one for somatoform symptoms such as pain and others.The indications are authorized to any kind of depressive disorders and generalized anxiety disorder in China.Compared by other formulations,controlled released one is most widely prescribed in China.It is well-known that venlafaxine and its controlled released formulations show relatively special characters in its psychopharmacologies,pharmacodynamics,and pharmacokinetics.To further clarify applied strategy in achieving optimum effect of venlafaxine formulation during clinic,some national famous expects wrote the consensus based on the international practice guidelines in depressive disorder and anxiety disorder,evidence-based medicine combined by their own experiences.The expert consensus involved clinical effect evidence,strategy,safety concern in treating patients with depressive disorders,generalized anxiety disorder and related conditions.Application and cautions in special population of aged,childhood and adolescents,gestation and breast feeding is also discussed.